Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7221 p595
26 October 2002

This article
Reprint
Photocopy


News summary

 


Low plasma folate levels increase miscarriage rates

Low plasma folate levels increase the risk of miscarriage by about 50 per cent, according to researchers from the Karolinska Institute in Stockholm. Furthermore, they say there is no excess risk for women with high levels of plasma folate (JAMA 2002;288:1867).

Dr Lena George and colleagues looked at the association between levels of plasma folate and risk of miscarriage after some earlier studies suggested that both folic acid deficiency and use of folic acid supplements could cause spontaneous abortion. Between 1996 and 1998 they identified 562 women who had had a spontaneous abortion and who agreed to participate in the study. Control cases were selected from pregnant women seeking prenatal care. Plasma folate levels were measured at the time of miscarriage diagnosis or at interview (controls).

The researchers found that compared with women with plasma folate levels of between 5.0 and 8.9 nmol/L, women with low folate levels (4.9nmol/L or below) had a higher risk of spontaneous abortion (adjusted odds ratio 1.47, 95 per cent confidence interval 1.01–2.14). Women with higher plasma folate levels (between 9.0 and 13.9nmol/L, and 14.0nmol/L or above) showed no increased risk of spontaneous abortion (OR 0.84, 0.59–1.20 and OR 0.74, 0.47–1.16, respectively). “Given the concern that folic acid supplements, which produce high folate levels, may increase abortion rates, this is an important finding,” they say.

The researchers add that their results have important public health and clinical implications. They conclude: “Countries that have fortified their food supplies with folic acid and those considering doing so can be reassured that fortification most likely will not increase spontaneous abortion rates and might even decrease them.”

 

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal